Therapeutic compounds for treating dyslipidemic conditions

Compounds of Formula I 1 and the pharmaceutically acceptable salts and esters thereof, wherein Z is selected from the group consisting of: (a) Formula Ia 2  and (b) Formula Ib 3 are novel LXR agonists and are useful in the treatment of dyslipidemic conditions particularly depressed levels of HDL cho...

Full description

Saved in:
Bibliographic Details
Main Authors Adams, Alan, Bouffard, Aileen, Dropinski, James, Gutteridge, Clare, Jones, A, Lui, Weiguo, Ondeyka, John, Shiafee, Ali, Singh, Sheo
Format Patent
LanguageEnglish
Published 03.07.2003
Online AccessGet full text

Cover

More Information
Summary:Compounds of Formula I 1 and the pharmaceutically acceptable salts and esters thereof, wherein Z is selected from the group consisting of: (a) Formula Ia 2  and (b) Formula Ib 3 are novel LXR agonists and are useful in the treatment of dyslipidemic conditions particularly depressed levels of HDL cholesterol.